Sana Biotechnology, Inc. (SANA)
3.785
-0.12
(-3.20%)
USD |
NASDAQ |
Aug 24, 16:00
3.785
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Debt to Equity Ratio : 0.4771 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4771 |
| March 31, 2026 | 0.6317 |
| December 31, 2025 | 0.4902 |
| September 30, 2025 | 0.4211 |
| June 30, 2025 | 0.6976 |
| March 31, 2025 | 0.4367 |
| December 31, 2024 | 0.376 |
| September 30, 2024 | 0.3285 |
| June 30, 2024 | 0.2902 |
| March 31, 2024 | 0.2828 |
| December 31, 2023 | 0.3621 |
| September 30, 2023 | 0.2648 |
| June 30, 2023 | 0.3187 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.2674 |
| December 31, 2022 | 0.2168 |
| September 30, 2022 | 0.1975 |
| June 30, 2022 | 0.1777 |
| March 31, 2022 | 0.1598 |
| December 31, 2021 | 0.1523 |
| September 30, 2021 | 0.1192 |
| June 30, 2021 | 0.0796 |
| March 31, 2021 | 0.0797 |
| December 31, 2020 | 0.1666 |
| March 31, 2020 | |
| December 31, 2019 | 0.1754 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Twist Bioscience Corp. | 0.21 |
| Beam Therapeutics, Inc. | 0.2317 |
| Prime Medicine, Inc. | 2.825 |
| Intellia Therapeutics, Inc. | 0.1009 |
| Moderna, Inc. | 0.1904 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 431.52M |
| Total Liabilities (Quarterly) | 276.95M |
| Shareholders Equity (Quarterly) | 154.57M |
| Current Ratio | 1.379 |
| Net Debt Paydown Yield | 0.34% |